内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-19 · 构建时间： 2026-10-19 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Anika Therapeutics, Inc.

ANIK · Nasdaq · CIK 0000898437 · Healthcare · Drug Manufacturers—Specialty & Generic

内部人信号

58.5 / 100

3 位买方 · 4 条买入交易行 · $264.3K 买入总额

为什么有这个信号？

买方广度中等
买入规模中等
角色中等
近期性较低
确信度较强
评分构成

每条进度条表示其对当前分数的贡献；权重和公式保持不变。

Cluster+21.0 / 35
买入规模+11.7 / 25
角色+13.0 / 20
近期性+2.8 / 10
确信度+10.0 / 10

哪些因素限制了当前分数？

  • ⚠ Cluster breadth is moderate · 3 insider(s), not 4+
  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ 角色得分低 · 买入者中职位最高的是：President and CEO（CEO、董事长和持股 10% 以上的股东得分最低）
  • ⚠ Purchase activity is becoming less recent

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

买方广度与集中度

合资格买方3
买入集中度57%最大买方： Griffin Stephen D. · $149.9K
聚集买入 · 15天2 insiders峰值活动： 2026-04-30–2026-05-01

Roles in the peak window: Director, President and CEO. Concentration uses priced qualifying P lines only and does not change the saved score.

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Fischetti Gary PDirector
○●●
Griffin Stephen D.President and CEO
●○○
HENNEMAN JOHN B IIIDirector
●○
Richard StephenDirector
○
Capper Joseph HDirector
○
CONLEY SHERYL LDirector
○
● 买入▼ 卖出○ 其他

—

信号历史

58.5 / 100

最新留档分数

→ +0.0 pts相对上一个留档快照
  1. 58.9
  2. 58.8
  3. 58.7
  4. 58.5
  5. 58.5

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

近期 Form 4 活动

4买入
0卖出
31其他 Form 4 交易行
16SEC 申报 · 365天
买入4 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他7 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息，不影响内部人信号。

价格表现

1M
-6.7%
3M
+24.2%
6M
+32.7%
12M
+111.9%

波动率与流动性

波动率
55.9%
Beta
0.20
平均每日成交额
USD 1.9M

估值

市值
USD 262.0M
P/E
—

基本面

利润率
-9.8%
ROE
-7.7%
细分行业
Drug Manufacturers—Specialty & Generic

市场数据

价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance · 来自 SEC 申报文件：市值, 利润率, ROE · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-07-24 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
367,155
上期报告
381,376
日均成交量
83,024
回补天数
4.4

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-08-04Fischetti Gary P买入 (P)Common Stock1,000USD 20.32USD 20,320SEC 申报 ↗
2026-08-03Fischetti Gary P买入 (P)Common Stock1,000USD 20.75USD 20,750SEC 申报 ↗
2026-05-01HENNEMAN JOHN B III买入 (P)Common Stock5,000USD 14.66USD 73,300SEC 申报 ↗
2026-04-30Griffin Stephen D.买入 (P)Common Stock12,200USD 12.29USD 149,938SEC 申报 ↗
2022-05-11Colleran David买入 (P)Common Stock1,500USD 21.37USD 32,055SEC 申报 ↗
2022-03-14Colleran David买入 (P)Common Stock1,500USD 26.65USD 39,975SEC 申报 ↗
2022-03-11Thompson Jeffery S买入 (P)Common Stock2,000USD 24.66USD 49,320SEC 申报 ↗
2022-03-11Levitz Michael L买入 (P)Common Stock4,000USD 24.62USD 98,480SEC 申报 ↗
2022-03-11Blanchard Cheryl R买入 (P)Common Stock8,100USD 25.57USD 207,132SEC 申报 ↗
2021-08-12Levitz Michael L买入 (P)Common Stock777USD 40.21USD 31,243SEC 申报 ↗
2021-08-11Levitz Michael L买入 (P)Common Stock2,850USD 40.21USD 114,598SEC 申报 ↗
2021-05-18HENNEMAN JOHN B III买入 (P)Common Stock2,000USD 42.86USD 85,720SEC 申报 ↗

Form 4 申报证据

35 transaction lines in the latest 365-day window; 194 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-08-04Fischetti Gary P买入 (P)Common Stock1,000USD 20.32USD 20,320SEC 申报 ↗
2026-08-03Fischetti Gary P买入 (P)Common Stock1,000USD 20.75USD 20,750SEC 申报 ↗
2026-06-18Richard Stephen奖励／授予 (A)Common Stock10,402USD 0.00USD 0SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-08-04Fischetti Gary P买入 (P)Common Stock1,000USD 20.32USD 20,320SEC 申报 ↗
2026-08-03Fischetti Gary P买入 (P)Common Stock1,000USD 20.75USD 20,750SEC 申报 ↗
2026-06-18Richard Stephen奖励／授予 (A)Common Stock10,402USD 0.00USD 0SEC 申报 ↗
2026-06-18HENNEMAN JOHN B III奖励／授予 (A)Common Stock10,402USD 0.00USD 0SEC 申报 ↗
2026-06-18Fischetti Gary P奖励／授予 (A)Common Stock10,402USD 0.00USD 0SEC 申报 ↗
2026-06-18Capper Joseph H奖励／授予 (A)Common Stock10,402USD 0.00USD 0SEC 申报 ↗
2026-06-18CONLEY SHERYL L奖励／授予 (A)Common Stock10,402USD 0.00USD 0SEC 申报 ↗
2026-06-03Griffin Stephen D.期权行权／转换 (M)Common Stock12,840USD —USD —SEC 申报 ↗
2026-06-03Griffin Stephen D.代扣税 (F)Common Stock3,769USD 14.41USD 54,311SEC 申报 ↗
2026-05-01HENNEMAN JOHN B III买入 (P)Common Stock5,000USD 14.66USD 73,300SEC 申报 ↗
2026-04-30Griffin Stephen D.买入 (P)Common Stock12,200USD 12.29USD 149,938SEC 申报 ↗
2026-03-15McLeod Ian期权行权／转换 (M)Common Stock2,658USD —USD —SEC 申报 ↗
2026-03-15McLeod Ian代扣税 (F)Common Stock781USD 14.20USD 11,090SEC 申报 ↗
2026-03-15Colleran David期权行权／转换 (M)Common Stock6,449USD —USD —SEC 申报 ↗
2026-03-15Colleran David代扣税 (F)Common Stock1,893USD 14.20USD 26,881SEC 申报 ↗
2026-03-15Blanchard Cheryl R期权行权／转换 (M)Common Stock25,131USD —USD —SEC 申报 ↗
2026-03-15Blanchard Cheryl R代扣税 (F)Common Stock12,104USD 14.20USD 171,877SEC 申报 ↗
2026-03-14McLeod Ian期权行权／转换 (M)Common Stock3,774USD —USD —SEC 申报 ↗
2026-03-14McLeod Ian代扣税 (F)Common Stock1,449USD 14.20USD 20,576SEC 申报 ↗
2026-03-14McLeod Ian奖励／授予 (A)Common Stock1,161USD 0.00USD 0SEC 申报 ↗
2026-03-14Griffin Stephen D.期权行权／转换 (M)Common Stock12,824USD —USD —SEC 申报 ↗
2026-03-14Griffin Stephen D.代扣税 (F)Common Stock5,944USD 14.20USD 84,405SEC 申报 ↗
2026-03-14Griffin Stephen D.奖励／授予 (A)Common Stock6,412USD 0.00USD 0SEC 申报 ↗
2026-03-14Colleran David期权行权／转换 (M)Common Stock9,388USD —USD —SEC 申报 ↗
2026-03-14Colleran David代扣税 (F)Common Stock4,168USD 14.20USD 59,186SEC 申报 ↗
2026-03-14Colleran David奖励／授予 (A)Common Stock4,694USD 0.00USD 0SEC 申报 ↗
2026-03-14Blanchard Cheryl R期权行权／转换 (M)Common Stock24,519USD —USD —SEC 申报 ↗
2026-03-14Blanchard Cheryl R代扣税 (F)Common Stock14,728USD 14.20USD 209,138SEC 申报 ↗
2026-03-14Blanchard Cheryl R奖励／授予 (A)Common Stock24,520USD 0.00USD 0SEC 申报 ↗
2026-03-09McLeod Ian期权行权／转换 (M)Common Stock2,197USD —USD —SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-19
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码ANIK
CIK0000898437
行业Healthcare
细分行业Drug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC3841 Surgical & Medical Instruments & Apparatus
交易所Nasdaq

数据覆盖

本地 Form 4 历史194 transaction lines from 2020-02-04 to 2026-08-04
13 P purchase lines · 4 S sale lines · 177 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.